| 14/0204/15-S |
4311B |
Yanimo Respimat 2,5 mikrogramu/2,5 mikrogramu inhala?ný roztok |
sol ihl 8x(1 inh.+1 nápl?/60 vstrekov) (nápl? PE/PP) |
BOE |
16.06.2020 |
| 14/0204/15-S |
4310B |
Yanimo Respimat 2,5 mikrogramu/2,5 mikrogramu inhala?ný roztok |
sol ihl 3x(1 inh.+1 nápl?/60 vstrekov) (nápl? PE/PP) |
BOE |
16.06.2020 |
| 14/0204/15-S |
4309B |
Yanimo Respimat 2,5 mikrogramu/2,5 mikrogramu inhala?ný roztok |
sol ihl 2x(1 inh.+1 nápl?/60 vstrekov) (nápl? PE/PP) |
BOE |
16.06.2020 |
| 14/0204/15-S |
4308B |
Yanimo Respimat 2,5 mikrogramu/2,5 mikrogramu inhala?ný roztok |
sol ihl 1x(1 inh.+1 nápl?/60 vstrekov) (nápl? PE/PP) |
BOE |
16.06.2020 |
| EU/1/97/055/002 |
41222 |
Viramune 50 mg/5 ml perorálna suspenzia |
sus por 1x240 ml (f?a.HDPE) |
BOE |
|
| EU/1/97/055/005 |
11446 |
Viramune 50 mg tablety s pred?ženým uvo??ovaním |
tbl plg 180x50 mg (f?. HDPE) |
BOE |
|
| EU/1/97/055/009 |
11450 |
Viramune 400 mg tablety s pred?ženým uvo??ovaním |
tbl plg 90x400 mg (fblis.PVC/Alu) |
BOE |
|
| EU/1/97/055/008 |
11449 |
Viramune 400 mg tablety s pred?ženým uvo??ovaním |
tbl plg 30x400 mg (fblis.PVC/Alu) |
BOE |
|
| EU/1/97/055/007 |
11448 |
Viramune 400 mg tablety s pred?ženým uvo??ovaním |
tbl plg 30x400 mg (f?. HDPE) |
BOE |
|
| EU/1/97/055/004 |
80026 |
Viramune 200 mg tablety |
tbl 14x200 mg (blis.PVC/Alu) |
BOE |
|
| EU/1/97/055/003 |
35254 |
Viramune 200 mg tablety |
tbl 120x200 mg (blis.PVC/Alu) |
BOE |
|
| EU/1/97/055/001 |
64988 |
Viramune 200 mg tablety |
tbl 60x200 mg (blis.PVC/Alu) |
BOE |
|
| EU/1/97/055/006 |
11447 |
Viramune 100 mg tablety s pred?ženým uvo??ovaním |
tbl plg 90x100 mg (f?. HDPE) |
BOE |
|
| EU/1/14/954/004 |
3136B |
Vargatef 150 mg mäkké kapsuly |
cps mol 60x150 mg (blis.Al/Al) |
BOE |
21.11.2019 |
| EU/1/14/954/003 |
3135B |
Vargatef 100 mg mäkké kapsuly |
cps mol 120(60x2)x100 mg (blis.Al/Al) |
BOE |
21.11.2019 |
| EU/1/14/954/002 |
3134B |
Vargatef 100 mg mäkké kapsuly |
cps mol 120x100 mg (blis.Al/Al) |
BOE |
21.11.2019 |
| EU/1/14/954/001 |
3133B |
Vargatef 100 mg mäkké kapsuly |
cps mol 60x100 mg (blis.Al/Al) |
BOE |
21.11.2019 |
| EU/1/10/648/021 |
01543 |
Twynsta 80 mg/5 mg tablety |
tbl 360(4x90)x1x80 mg/5 mg (blis.PA/Al/PVC/Al) |
BOE |
|
| EU/1/10/648/020 |
01542 |
Twynsta 80 mg/5 mg tablety |
tbl 98x80 mg/5 mg (blis.PA/Al/PVC/Al) |
BOE |
|
| EU/1/10/648/019 |
01541 |
Twynsta 80 mg/5 mg tablety |
tbl 90x1x80 mg/5 mg (blis.PA/Al/PVC/Al) |
BOE |
|
| EU/1/10/648/018 |
01540 |
Twynsta 80 mg/5 mg tablety |
tbl 56x80 mg/5 mg (blis.PA/Al/PVC/Al) |
BOE |
|
| EU/1/10/648/017 |
01539 |
Twynsta 80 mg/5 mg tablety |
tbl 30x1x80 mg/5 mg (blis.PA/Al/PVC/Al) |
BOE |
|
| EU/1/10/648/016 |
01538 |
Twynsta 80 mg/5 mg tablety |
tbl 28x80 mg/5 mg (blis.PA/Al/PVC/Al) |
BOE |
|
| EU/1/10/648/015 |
01537 |
Twynsta 80 mg/5 mg tablety |
tbl 14x80 mg/5 mg (blis.PA/Al/PVC/Al) |
BOE |
|
| EU/1/10/648/028 |
01551 |
Twynsta 80 mg/10 mg tablety |
tbl 360(4x90)x1x80 mg/10 mg (blis.PA/Al/PVC/Al) |
BOE |
|
| EU/1/10/648/027 |
01550 |
Twynsta 80 mg/10 mg tablety |
tbl 98x80 mg/10 mg (blis.PA/Al/PVC/Al) |
BOE |
|
| EU/1/10/648/026 |
01549 |
Twynsta 80 mg/10 mg tablety |
tbl 90x1x80 mg/10 mg (blis.PA/Al/PVC/Al) |
BOE |
|
| EU/1/10/648/025 |
01548 |
Twynsta 80 mg/10 mg tablety |
tbl 56x80 mg/10 mg (blis.PA/Al/PVC/Al) |
BOE |
|
| EU/1/10/648/024 |
01547 |
Twynsta 80 mg/10 mg tablety |
tbl 30x1x80 mg/10 mg (blis.PA/Al/PVC/Al) |
BOE |
|
| EU/1/10/648/023 |
01545 |
Twynsta 80 mg/10 mg tablety |
tbl 28x80 mg/10 mg (blis.PA/Al/PVC/Al) |
BOE |
|
| EU/1/10/648/022 |
01544 |
Twynsta 80 mg/10 mg tablety |
tbl 14x80 mg/10 mg (blis.PA/Al/PVC/Al) |
BOE |
|
| EU/1/10/648/007 |
01527 |
Twynsta 40 mg/5 mg tablety |
tbl 360(4x90)x1x40 mg/5 mg (blis.PA/Al/PVC/Al) |
BOE |
|
| EU/1/10/648/006 |
01526 |
Twynsta 40 mg/5 mg tablety |
tbl 98x40 mg/5 mg (blis.PA/Al/PVC/Al) |
BOE |
|
| EU/1/10/648/005 |
01523 |
Twynsta 40 mg/5 mg tablety |
tbl 90x1x40 mg/5 mg (blis.PA/Al/PVC/Al) |
BOE |
|
| EU/1/10/648/004 |
01522 |
Twynsta 40 mg/5 mg tablety |
tbl 56x40 mg/5 mg (blis.PA/Al/PVC/Al) |
BOE |
|
| EU/1/10/648/003 |
01520 |
Twynsta 40 mg/5 mg tablety |
tbl 30x1x40 mg/5 mg (blis.PA/Al/PVC/Al) |
BOE |
|
| EU/1/10/648/002 |
01519 |
Twynsta 40 mg/5 mg tablety |
tbl 28x40 mg/5 mg (blis.PA/Al/PVC/Al) |
BOE |
|
| EU/1/10/648/001 |
01517 |
Twynsta 40 mg/5 mg tablety |
tbl 14x40 mg/5 mg (blis.PA/Al/PVC/Al) |
BOE |
|
| EU/1/10/648/014 |
01536 |
Twynsta 40 mg/10 mg tablety |
tbl 360(4x90)x1x40 mg/10 mg (blis.PA/Al/PVC/Al) |
BOE |
|
| EU/1/10/648/013 |
01535 |
Twynsta 40 mg/10 mg tablety |
tbl 98x40 mg/10 mg (blis.PA/Al/PVC/Al) |
BOE |
|
| EU/1/10/648/012 |
01534 |
Twynsta 40 mg/10 mg tablety |
tbl 90x1x40 mg/10 mg (blis.PA/Al/PVC/Al) |
BOE |
|
| EU/1/10/648/011 |
01533 |
Twynsta 40 mg/10 mg tablety |
tbl 56x40 mg/10 mg (blis.PA/Al/PVC/Al) |
BOE |
|
| EU/1/10/648/010 |
01532 |
Twynsta 40 mg/10 mg tablety |
tbl 30x1x40 mg/10 mg (blis.PA/Al/PVC/Al) |
BOE |
|
| EU/1/10/648/009 |
01531 |
Twynsta 40 mg/10 mg tablety |
tbl 28x40 mg/10 mg (blis.PA/Al/PVC/Al) |
BOE |
|
| EU/1/10/648/008 |
01529 |
Twynsta 40 mg/10 mg tablety |
tbl 14x40 mg/10 mg (blis.PA/Al/PVC/Al) |
BOE |
|
| EU/1/11/707/011 |
10798 |
Trajenta 5 mg filmom obalené tablety |
tbl flm 120x5 mg (blis.Al/Al) |
BOE |
|
| EU/1/11/707/010 |
10797 |
Trajenta 5 mg filmom obalené tablety |
tbl flm 100x5 mg (blis.Al/Al) |
BOE |
|
| EU/1/11/707/009 |
10796 |
Trajenta 5 mg filmom obalené tablety |
tbl flm 98x5 mg (blis.Al/Al) |
BOE |
|
| EU/1/11/707/008 |
10795 |
Trajenta 5 mg filmom obalené tablety |
tbl flm 90x5 mg (blis.Al/Al) |
BOE |
|
| EU/1/11/707/007 |
10794 |
Trajenta 5 mg filmom obalené tablety |
tbl flm 84x5 mg (blis.Al/Al) |
BOE |
|
1
